Showing results (141-150 of 244) with videos related to

Sort By:
Pageof 25
JCO Precision Oncology|September 11, 2020
Multiplex Gene Profiling of Cell-Free DNA in Patients With Metastatic Melanoma for Monitoring DiseaseSelena Y Lin, Sharon K Huang, Kelly T Huynh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestineFarin F Amersi, Alicia M Terando, Yasufumi Goto, et al.
Clinical Chemistry|January 10, 2009
Multimarker circulating DNA assay for assessing blood of prostate cancer patientsEiji Sunami, Masaru Shinozaki, Celestia S Higano, et al.
Oncotarget|November 5, 2017
ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasisSivan Izraely, Shlomit Ben-Menachem, Orit Sagi-Assif, et al.
Clinical Chemistry|October 4, 2023
Diagnostic miRNA Signatures in Paired Tumor, Plasma, and Urine Specimens From Renal Cell Carcinoma PatientsMatias A Bustos, Josh Gottlieb, Jane Choe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodesTaku Nakagawa, Steve R Martinez, Yasufumi Goto, et al.
The Journal of Investigative Dermatology|September 2, 2006
Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanomaPeter D Boasberg, Dave S B Hoon, Lawrence D Piro, et al.
The Journal of Clinical Investigation|November 11, 2014
RASAL2 activates RAC1 to promote triple-negative breast cancer progressionMin Feng, Yi Bao, Zhimei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trialKazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.
Pageof 25